Syngenis joins WA research heavyweights in RNA medicine push
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.
Lean: Leans left
Fact-focusedFactuality: HighCountry: AustraliaFunding: CorporateOwner: Nine Entertainment
Coverage breakdown
Funding
Corporate100%
Countries
Australia100%
Media ownership
Nine Entertainment100%
Avg reliability78
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 42 (Limited corroboration)
Propaganda risk: 0
Trending: Low
Sources: 1
Reliability: 78
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 0
Amplification: 0